Cerebrospinal Fluid Amyloid‐β Biomarkers Predict Future Hemorrhage in Patients with Cerebral Amyloid Angiopathy
Annals of Neurology · 2026-08 · 100 (2) · 391-399
DOI: 10.1002/ana.78241 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Neurology, online erschienen am 27.04.2026. Verfasst von Philipp Arndt und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Otto-von-Guericke University, Magdeburg, Germany. Hauptthemen laut MEDLINE: Cerebral Amyloid Angiopathy, Amyloid beta-Peptides, Peptide Fragments, Intracranial Hemorrhages. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Accurately predicting future hemorrhagic events in patients with cerebral amyloid angiopathy (CAA) remains a major clinical challenge. It is unknown whether cerebrospinal fluid (CSF) biomarkers of amyloid‐beta (Aβ) pathology are associated with increased hemorrhage risk in this population.
Methods
We analyzed consecutive patients meeting Boston criteria version 2.0 for probable CAA with CSF Aβ data obtained during diagnostic workup. The primary outcome was incident intracranial hemorrhage, including lobar intracerebral, convexity subarachnoid, and non‐traumatic subdural hemorrhage. Secondary outcomes were ischemic stroke and all‐cause mortality. Associations between low CSF Aβ biomarkers and outcomes were analyzed using Cox proportional hazards models, adjusted for disseminated cortical superficial siderosis, and prior intracerebral hemorrhage.
Results
Among 109 patients (median age: 77 years, 42% female), 16 (15%) experienced incident intracranial hemorrhage and 11 (10%) incident ischemic stroke during a median follow‐up of 2.93 years (interquartile range: 1.43–5.03). In multivariate Cox regression models low CSF Aβ biomarkers were independently associated with incident intracranial hemorrhage (Aβ 40 : hazard ratio: 8.04; [95% CI: 2.43–26.59], p < 0.001; Aβ 42 : hazard ratio 7.10; [95% CI: 1.58–32.00], p = 0.011). CSF Aβ biomarkers were not associated with incident ischemic strokes and all‐cause mortality. A composite risk score integrating low CSF Aβ biomarkers and hemorrhagic imaging features identified a high‐risk subgroup with 78% hemorrhage incidence (7/9 patients) and a no‐risk group without events (0/42 patients).
Interpretation
Low CSF Aβ biomarkers are independently associated with future symptomatic hemorrhage in CAA patients. A composite risk score may support individualized risk stratification and guide clinical decision‐making. ANN NEUROL 2026;100:391–399
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Otto-von-Guericke University, Magdeburg, Germany.
- German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, Magdeburg, Germany.
- J. Philip Kistler Stroke Research Center, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA.
- Biomedical Magnetic Resonance, Faculty of Natural Sciences, Otto-von-Guericke University, Magdeburg, Germany.
- Center for Behavioral Brain Sciences, Magdeburg, Germany.
- Department of Consultation-Liaison-Psychiatry and Psychosomatic Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
ORCID-Profile: Philipp Arndt, Valentina Perosa, Sebastian J Müller
Zitieren
APA
Arndt, P., Pfister, M., Perosa, V., Mattern, H., Tas, M., Holzheimer, L., Engel, J., Dörner, M., Al-Dubai, M., Garz, C., Khadhraoui, E., Müller, S. J., Müller, P., Meuth, S. G., Neumann, K., & Schreiber, S. (2026). Cerebrospinal Fluid Amyloid‐β Biomarkers Predict Future Hemorrhage in Patients with Cerebral Amyloid Angiopathy. Annals of Neurology, 100(2), 391-399. https://doi.org/10.1002/ana.78241
Vancouver
Arndt P, Pfister M, Perosa V, Mattern H, Tas M, Holzheimer L, et al. Cerebrospinal Fluid Amyloid‐β Biomarkers Predict Future Hemorrhage in Patients with Cerebral Amyloid Angiopathy. Annals of Neurology. 2026;100(2):391-399. doi:10.1002/ana.78241
BibTeX
@article{Arndt2026,
author = {Arndt, Philipp and Pfister, Malte and Perosa, Valentina and Mattern, Hendrik and Tas, Melis and Holzheimer, Lara and Engel, Johanna and Dörner, Marc and Al-Dubai, Marwa and Garz, Cornelia and Khadhraoui, Eya and Müller, Sebastian J and Müller, Patrick and Meuth, Sven G and Neumann, Katja and Schreiber, Stefanie},
title = {Cerebrospinal Fluid Amyloid‐β Biomarkers Predict Future Hemorrhage in Patients with Cerebral Amyloid Angiopathy},
journal = {Annals of Neurology},
year = {2026},
volume = {100},
number = {2},
pages = {391--399},
doi = {10.1002/ana.78241}
}
EUVIMED